Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Consumers Making Effort To Buy Healthy Foods But Buyer Beware: "Zero" Isn't Always Zero
Americans trying to eat healthier are looking to nutrition labels to help make better choices at the grocery store. But consumers who take those labels at face value may find they"re not eating as healthy as they think.

New Guidelines To Standardise Access Criteria For IVF Treatment
The National Infertility Awareness Campaign (NIAC) welcomed the document "Standardising Access Criteria to NHS Fertility Treatment"1 produced by Infertility Network UK (I N UK) and funded by the Department of Health.
News of the day
Poniard Pharmaceuticals Announces Positive Efficacy And Safety Data From Phase 2 Clinical Trial Of Picoplatin In Men With Metastatic Prostate Cancer
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced updated efficacy and safety data from its Phase 2 clinical trial of picoplatin in patients with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The data demonstrate that picoplatin in combination with docetaxel and prednisone is active as first-line therapy for metastatic CRPC. This was demonstrated by several endpoints, including reductions in prostate specific antigen (PSA) levels, disease control as measured by tumor response, and progression-free survival (PFS). Results also continue to show that picoplatin can be safely administered every three weeks for up to 10 cycles concurrently with full doses of docetaxel and prednisone, the standard treatment for CRPC. In addition, no neurotoxicity was observed in these patients.
Endocrinology

Upcoming Health IT Decisions Could Spell Success Or Failure

"An unprecedented effort to computerize the nation"s hospitals and physician offices could be the key to reducing crippling health care costs - or a giveaway to technology vendors whose sales will be subsidized by taxpayers," the Dallas Morning News reports. The $45 billion, stimulus-funded effort in question could help reduce costs by cutting into the country"s $37.6 billion in medical errors each year, for instance. But, if requirements for providers seeking stimulus funding are too strict, the program could turn into "a bonanza for software vendors." Those requirements - called "meaningful use" - will be defined by the end of the year. A second draft of the definition is due out this week. An earlier draft, "produced by a federal advisory panel, resembled an approach advocated by the Healthcare Information and Management Systems Society. The government"s draft, however, was more aggressive." Meanwhile "Hospitals, physician groups and technology vendors have said the draft would require them to do too much too soon" (Michaels and Roberson, 7/14). The Morning News also has a brief wrap-up of key health IT points. Hospitals that don"t have electronic record systems in place by 2015 will not get the stimulus money and will instead face penalties. Those penalties are not yet defined. The records systems must be certified, and must be able to exchange data with other systems (7/14). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009